Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
Tamara Pérez-Jeldres, Manuel Álvarez-Lobos, Jesús Rivera–Nieves
Drugs (2021) Vol. 81, Iss. 9, pp. 985-1002
Open Access | Times Cited: 143

Showing 26-50 of 143 citing articles:

Synthetic Approaches to the New Drugs Approved During 2021
Emma L. McInturff, Scott P. France, Carolyn A. Leverett, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10150-10201
Closed Access | Times Cited: 15
How to get rid of itching
Ashley Vander Does, Teresa Ju, Noreen Mohsin, et al.
Pharmacology & Therapeutics (2023) Vol. 243, pp. 108355-108355
Closed Access | Times Cited: 14
S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway
Yi-Ping Tao, Heng-Yan Zhu, Qian-Yuan Shi, et al.
Oncogene (2023) Vol. 42, Iss. 47, pp. 3491-3502
Open Access | Times Cited: 13
Neutrophil extracellular traps in central nervous system (CNS) diseases
Bo‐Zong Shao, Jingjing Jiang, Yicheng Zhao, et al.
PeerJ (2024) Vol. 12, pp. e16465-e16465
Open Access | Times Cited: 5
Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
Hongwei Guo, Zhiming Ye, Siqi Chen, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 11, pp. 1321-1338
Closed Access | Times Cited: 5
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review
Victor Constantinescu, Rocco Haase, Katja Akgün, et al.
Therapeutic Advances in Neurological Disorders (2022) Vol. 15
Open Access | Times Cited: 19
Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline
Chi Chiu Mok
Drugs (2023) Vol. 83, Iss. 6, pp. 479-496
Open Access | Times Cited: 11
Prmt5 deficiency inhibits CD4+ T-cell Klf2/S1pr1 expression and ameliorates EAE disease
Yingxia Zheng, Zheyi Chen, Bingqian Zhou, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 11
Nuclear SphK2/S1P signaling is a key regulator of ApoE production and Aβ uptake in astrocytes
Masato Komai, Yuka Noda, Atsuya Ikeda, et al.
Journal of Lipid Research (2024) Vol. 65, Iss. 3, pp. 100510-100510
Open Access | Times Cited: 4
An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators
Wanting Hao, Dongdong Luo, Yuqi Jiang, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2331-2362
Closed Access | Times Cited: 4
Safety and Effectiveness of Thiopurines and Small Molecules in Elderly Patients with Inflammatory Bowel Diseases
Aleksandra Strigáč, M Caban, Ewa Małecka‐Panas, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4678-4678
Open Access | Times Cited: 4
Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management
Celia Oreja‐Guevara, Sergio Martínez‐Yélamos, Sara Eichau, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access | Times Cited: 4
Innovative Approaches to Psoriasis: Small Molecules Targeting Key Signaling Pathways
Meeral Gosia, Gaurav Doshi, Siddhi Bagwe Parab, et al.
Immunological Investigations (2025), pp. 1-37
Closed Access
Revealing the role of natural killer cells in ankylosing spondylitis: identifying diagnostic biomarkers and therapeutic targets
Yuling Chen, Yan Li, Yuan Xu, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Sphingosine-1-phosphate signaling regulates the ability of Müller glia to become neurogenic, proliferating progenitor-like cells
Olivia Taylor, Nick DeGroff, Heithem M. El‐Hodiri, et al.
(2025)
Open Access
Sphingosine-1-phosphate signaling through Müller glia regulates neuroprotection and the accumulation of immune cells in the rodent retina
Olivia Taylor, Lisa E. Kelly, Heithem M. El‐Hodiri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
An unraveled mystery: What's the role of brain sphingolipids in neurodegenerative and psychiatric disorders
Xintian Bie, Min Zhang, Qingyu Wang, et al.
Neurobiology of Disease (2025) Vol. 207, pp. 106852-106852
Open Access
Small Molecules in the Treatment of Acute Severe Ulcerative Colitis: A Review of Current Evidence
Raffaele Pellegrino, Giuseppe Imperio, Ilaria De Costanzo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 308-308
Open Access
Sphingosine-1-phosphate signaling regulates the ability of Müller glia to become neurogenic, proliferating progenitor-like cells
Olivia B. Taylor, Nicholas DeGroff, Heithem M. El‐Hodiri, et al.
eLife (2025) Vol. 13
Open Access
The Potential Capacities of FTY720: Novel Therapeutic Functions, Targets, and Mechanisms against Diseases
Juan Liu, Lu Zhang, Le Liu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117508-117508
Open Access
FTY720 alleviates HBV-mediated inflammatory liver injury through a dual role of inhibiting lymphocyte trafficking and viral replication
Juan Liu, Yinxia Zhao, Ya‐Hui Song, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114495-114495
Closed Access
Cerebrospinal fluid metabolomics in autistic regression reveals dysregulation of sphingolipids and decreased β-hydroxybutyrate
Jingya Yan, Velda X. Han, Hannah Jones, et al.
EBioMedicine (2025) Vol. 114, pp. 105664-105664
Closed Access
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data
Nunzia Balzano, Raffaella Di Napoli, Federica Fraenza, et al.
Pharmacological Reports (2025)
Open Access
lncRNA PAN3-AS1 Modulates Cilium Assemble Signaling Pathway Through Regulation of RPGR as a Potential MS Diagnostic Biomarker: Integrated Systems Biology Investigation
Yasaman Mostaghimi, Mohammad Haddadi, Zohreh Hojjati
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 2
Closed Access
Management of the most prevalent autoimmune diseases coexisting in multiple sclerosis.
Ana B. Caminero
Neurology Perspectives (2025), pp. 100194-100194
Open Access

Scroll to top